je.st
news
Tag: secondary
Secondary Offerings Have Saved Oil Stocks - Cramer's Mad Money
2016-03-08 19:51:08| Oil & Gas - Topix.net
The markets have a strange way of recovering themselves. There is a rally in commodity based stocks that began with short-covering, but secondary stock offerings saved the day.
Tags: money
oil
secondary
saved
The Secondary Effects of Lightning Activity
2016-03-07 01:00:00| Hydrocarbons Technology
The trend toward miniaturisation in electronic systems brings an increased sensitivity to electrical transient phenomena.
Tags: activity
effects
secondary
lightning
Species Claims Invalidated by Genus Prior Art and a Lack of Secondary ...
2016-03-05 21:06:35| Biotech - Topix.net
Species Claims Invalidated by Genus Prior Art and a Lack of Secondary Indicia of Non-Obviousness ) The U.S. Court of Appeals for the Federal Circuit upheld the U.S. District Court for the District of New Jersey's finding of patent invalidity on the basis of obviousness, but did not reach the issue of invalidity due to double patenting, in this Hatch-Waxman patent infringement action. Prometheus Laboratories, Inc. v.
02.02.16 -- When Secondary Containment Linings And Coatings Are Primary
2016-02-23 01:22:34| chemicalonline Home Page
02/02/16Chemical Online Newsletter
Tags: are
primary
secondary
coatings
Mercks Investigational Once-Daily Formulation of ISENTRESS (raltegravir) Meets Primary and Secondary Endpoints in Pivotal Phase 3 Study
2016-02-22 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Results to be Presented at Future Medical Meeting, and Regulatory Submissions Planned for 2016 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced top-line results from the companys Phase 3 pivotal trial, ONCEMRK. ONCEMRK is evaluating an investigational once-daily formulation of ISENTRESS (raltegravir), known as raltegravir 600 mg (to be given as 2 x 600 mg once-daily), for previously untreated HIV-1 infected adults. Language: English Contact: For MerckMedia:Pamela Eisele, 267-305-3558orCarmen de Gourville, 267-305-4195orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: study
primary
phase
secondary
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »